跳至主要内容
临床试验/NCT01001273
NCT01001273Unknown不适用

Hyperinsulinemic Normoglycemic Clamp for Pancreas and Simultaneous Pancreas/Kidney Transplant Recipients

McGill University Health Centre/Research Institute of the McGill University Health Centre2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2010年4月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
80
试验地点
2
主要终点
The number of post-transplants all complications up to 30 days (Clavien grading).

研究概览

简要总结

This study proposes a simple and safe way of lowering this complicate rate, while improving graft recovering and protecting the graft as it recovers from the transplant. The investigators hypothesize that by maintaining a tight glucose control via a glucose-insulin clamp during surgery and 72 hours post-operatively the investigators will be able to lower the complication rate by 50%.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female patient over 18 years of age
  • Patient is about to receive a pancreas or a simultaneous pancreas/kidney transplant
  • Able to give written informed consent prior to any study specific procedure

排除标准

  • Multi-organ transplant other than kidney transplant
  • No central venous access available to deliver the D20W solution

结局指标

主要结局

The number of post-transplants all complications up to 30 days (Clavien grading).

时间窗: 30 days post-operative

次要结局

  • The number of 30 days post-transplant serious medical complication (Clavien grade 3, 4)(30 days post-op)
  • The length of hospital stay (days)(Length of hospital stay (day 1 until discharge))

研究者

发起方
McGill University Health Centre/Research Institute of the McGill University Health Centre
申办方类型
Other

研究点 (2)

Loading locations...

相似试验